Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-05 7:14 pm Purchase | 13G | Aileron Therapeutics Inc. ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,812,627 6.200% | 1,812,627 (New Position) | View |
2024-02-14 10:28 am Purchase | 13G | Silver Point Specialty Lending Fund | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 5,004,910 13.600% | 5,004,910 (New Position) | View |
2021-09-23 6:56 pm Sale | 13G | TAYSHA GENE THERAPIES INC TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,156,255 3.010% | -1,022,745 (-46.94%) | View |
2021-02-16 1:35 pm Unchanged | 13G | TAYSHA GENE THERAPIES INC TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 0 (Unchanged) | View |
2021-02-03 6:14 pm Purchase | 13G | TAYSHA GENE THERAPIES INC TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | View |